Abbreviations
- M2BPGi:
-
Mac-2 Biding Protein Glycosylation isomer
- BA:
-
Biliary atresia
- LT:
-
Liver transplantation
- GI:
-
Gastrointestinal
- COI:
-
Cut off index
- HSCs:
-
Hepatic stellate cells
References
Shirabe K, Bekki Y, Gantumur D, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819–26.
Yamada N, Sanada Y, Tashiro M, et al. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol. 2017;52:245–52.
Funding
No financial support was provided for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Written informed consent was obtained from the patient’s family demonstrated in this letter.
Rights and permissions
About this article
Cite this article
Yamada, N., Mizuta, K. Advanced assessment of serum Mac-2 binding protein glycosylation isomer in patients with biliary atresia. J Gastroenterol 54, 204–205 (2019). https://doi.org/10.1007/s00535-018-1523-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-018-1523-6